Abbott India EV / EBITDA
Was ist das EV / EBITDA von Abbott India?
EV / EBITDA von Abbott India Limited ist 43.60
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Abbott India
Was macht Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
Unternehmen mit ev / ebitda ähnlich Abbott India
- PaySign hat EV / EBITDA von 43.41
- B & D Strategic hat EV / EBITDA von 43.44
- China Apex hat EV / EBITDA von 43.47
- Xref hat EV / EBITDA von 43.47
- AK Medical hat EV / EBITDA von 43.51
- Escorts hat EV / EBITDA von 43.55
- Abbott India hat EV / EBITDA von 43.60
- ADC India Communications hat EV / EBITDA von 43.63
- Elecon Engineering hat EV / EBITDA von 43.68
- V.S. International hat EV / EBITDA von 43.90
- Harvest Minerals hat EV / EBITDA von 43.94
- Pritish Nandy Communications Ltd hat EV / EBITDA von 43.96
- Satu hat EV / EBITDA von 44.04